Comparison of Generic Versus Personalized Text Messages for Diabetes Laboratory Monitoring: a Randomized Quality Improvement Study

J Gen Intern Med. 2023 Jun;38(8):2001-2002. doi: 10.1007/s11606-022-08010-5. Epub 2023 Jan 12.

Authors

Jeffrey Dong^{1

2}, Jonathan X Li^{1

2}, Naing Aung¹, Corey Smith¹, Timothy S Anderson^{3

4

5}

Affiliations

¹ Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
² Harvard Medical School, Boston, MA, USA.
³ Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA. tsander1@bidmc.harvard.edu.
⁴ Harvard Medical School, Boston, MA, USA. tsander1@bidmc.harvard.edu.
⁵ Center for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, Boston, MA, USA. tsander1@bidmc.harvard.edu.

PMID: 36635532
PMCID: PMC10272027 (available on 2024-06-01)
DOI: 10.1007/s11606-022-08010-5

No abstract available

Publication types

Letter
Randomized Controlled Trial
Research Support, N.I.H., Extramural

MeSH terms

Diabetes Mellitus* / diagnosis
Diabetes Mellitus* / therapy
Drugs, Generic
Humans
Quality Improvement
Text Messaging*

Substances

Drugs, Generic

Grants and funding